Sirpa Aaltomaa

PO Box 100, FI-70029 KYS
Kuopio, 70029, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).

Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 19, 2023

Postoperative pain in a prospectively assessed surgical short-stay cohort: A subgroup analysis.

Postoperative pain in a prospectively assessed surgical short-stay cohort: A subgroup analysis.

Journal: Acta anaesthesiologica Scandinavica

Published: May 10, 2022

Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.

Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.

Journal: European urology focus

Published: August 29, 2021

Patient functional recovery after a 23-h surgery - a prospective, follow-up study.

Patient functional recovery after a 23-h surgery - a prospective, follow-up study.

Journal: Langenbeck's archives of surgery

Published: May 27, 2021

Repeated 5-aminolevulinic Acid Instillations During Follow-up in Non-muscle-invasive Bladder Cancer: A Randomized Study.

Repeated 5-aminolevulinic Acid Instillations During Follow-up in Non-muscle-invasive Bladder Cancer: A Randomized Study.

Journal: In vivo (Athens, Greece)

Published: December 21, 2020

Stereotactic body radiotherapy for localized prostate cancer - 5-year efficacy results.

Stereotactic body radiotherapy for localized prostate cancer - 5-year efficacy results.

Journal: Radiation oncology (London, England)

Published: May 04, 2020

Cellular hyaluronan is associated with a poor prognosis in renal cell carcinoma.

Cellular hyaluronan is associated with a poor prognosis in renal cell carcinoma.

Journal: Urologic oncology

Published: January 20, 2020

Implementation of a 23-h surgery model in a tertiary care hospital: a safe and feasible model with high patient satisfaction.

Implementation of a 23-h surgery model in a tertiary care hospital: a safe and feasible model with high patient satisfaction.

Journal: BJS open

Published: November 21, 2019

Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.

Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.

Journal: BMC cancer

Published: November 11, 2019

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial.

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial.

Journal: World journal of urology

Published: April 02, 2019

Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

Journal: Brachytherapy

Published: February 22, 2019

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.

Journal: European urology

Published: November 23, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026